BioAegis Therapeutics
PrivateLast Round
Grant
Oct 16, 2023
Total Funding Raised
$50M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BioAegis Therapeutics operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was a Grant round in October 2023.
BioAegis Therapeutics is a clinical-stage biotechnology company developing therapies for inflammatory, infectious, and degenerative diseases based on its plasma gelsolin (pGSN) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioAegis Therapeutics Comparables
Compare BioAegis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aqualung Therapeutics Corporation | 82% | |
| Implicit Bioscience | 78% | |
| Trove Therapeutics | 77% |
For institutional investors. Book with your work email.
BioAegis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 16, 2023 | ||||
| Series C | Mar 22, 2022 | ||||
| Convertible Debt | Jun 23, 2020 | ||||
| Debt | Apr 28, 2020 | ||||
| VC Round | Sep 17, 2018 | ||||
Seed | Feb 8, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioAegis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 74% MoM, reaching 1.5K.
- Jan 21, 2026
Monthly visitors grew 95% MoM, reaching 1.3K.
For institutional investors. Book with your work email.
BioAegis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioAegis Therapeutics's valuation, stock price, and market status.
Is BioAegis Therapeutics a public or private company?
BioAegis Therapeutics is a private company.
What is the current stock price of BioAegis Therapeutics?
BioAegis Therapeutics is a private company, so its shares have no public market price. Caplight tracks BioAegis Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioAegis Therapeutics worth (valuation)?
Valuation information for BioAegis Therapeutics is not publicly available.
Can I buy BioAegis Therapeutics stock?
BioAegis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioAegis Therapeutics's last funding round?
BioAegis Therapeutics's most recent funding round was Grant on October 16, 2023.
Who are the main investors in BioAegis Therapeutics?
Key investors in BioAegis Therapeutics include Public Health Emergency Medical Countermeasures Enterprise.
Will BioAegis Therapeutics IPO soon?
No public IPO plans have been announced for BioAegis Therapeutics.
How can I track BioAegis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in BioAegis Therapeutics's shares on secondary markets.